Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $61.09 ($554K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $554k KITE by VP, Product Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.09 | 2,171 | $133K | 23.9% |
| 2 | $61.66 | 6,719 | $414K | 74.8% |
| 3 | $62.44 | 110 | $7K | 1.2% |
| Total | $61.53 avg | 9,000 | $554K | 100% |
| Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |
| KITE | SELL | 2015-09-03 | $466K | — | Filing → |